Gestrinone

This classification denotes a therapeutic progestin with the molecular formula C21H24O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1421533RCM, chemically known as 18,19-dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)- (9ci) but generally known as gestrinone, which bears US NIH Compound Identifier 27812. European Medicines Agency schedules Gestrinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13963MIG. The term GESTRINONE is an International Non-Proprietary Name. World Health Organization schedules gestrinone in its Anatomical Therapeutic Chemical (ATC) Classification. GESTRINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gestrinone under HS 29372300 and SITC 54153. As of Q4 2014, GESTRINONE remains the US FDA Preferred Term for this commodity. Gestrinone bears US NLM identifiers UMLS ID C0017507 and NCI Concept Code C87241. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C=C2)CC1)CC)C#C.